Role of miR-224 in hepatocellular carcinoma: a tool for possible therapeutic intervention?

TheMECP2duplication syndrome

(2010) Melissa B. Ramocki et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

MYC, microRNAs and glutamine addiction in cancers

(2010) Chi V. Dang   CELL CYCLE

MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling

(2010) Q. W-L. Wong et al.   CLINICAL CANCER RESEARCH

Serum microRNA characterization identifiesmiR-885-5pas a potential marker for detecting liver pathologies

(2010) Junhao Gui et al.   CLINICAL SCIENCE

Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3

(2010) Yu Wang et al.   JOURNAL OF HEPATOLOGY

Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo

(2010) Andelko Hrzenjak et al.   Molecular Cancer

MicroRNA-224 Is Involved in Transforming Growth Factor-β-Mediated Mouse Granulosa Cell Proliferation and Granulosa Cell Function by Targeting Smad4

(2010) Guidong Yao et al.   MOLECULAR ENDOCRINOLOGY

miR-21as a key regulator of oncogenic processes

(2009) S. Duygu Selcuklu et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation

(2009) Michela Garofalo et al.   CANCER CELL

MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity

(2009) H. Su et al.   CANCER RESEARCH

Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated

(2009) Xiao-Hui Huang et al.   HEPATOLOGY RESEARCH

MicroRNA-224is upregulated in HepG2 cells and involved in cellular migration and invasion

(2009) Qiong Li et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration

(2009) X Li et al.   ONCOGENE

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

(2009) C Coulouarn et al.   ONCOGENE

Distal Xq duplication and functional Xq disomy

(2009) Damien Sanlaville et al.   Orphanet Journal of Rare Diseases

miR-221 overexpression contributes to liver tumorigenesis

(2009) P. Pineau et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Elevated Expression of the miR-17–92 Polycistron and miR-21 in Hepadnavirus-Associated Hepatocellular Carcinoma Contributes to the Malignant Phenotype

(2008) Erin Connolly et al.   AMERICAN JOURNAL OF PATHOLOGY

Cancer Cell Metabolism: Warburg and Beyond

(2008) Peggy P. Hsu et al.   CELL

Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival

(2008) J. Jiang et al.   CLINICAL CANCER RESEARCH

Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma

(2008) Shunsuke Ura et al.   HEPATOLOGY

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations

(2008) Yannick Ladeiro et al.   HEPATOLOGY

Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific Target

(2008) Yu Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MicroRNA and cancer - focus on apoptosis

(2008) Yu Wang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Small non-coding RNAs in animal development

(2008) Giovanni Stefani et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

miRecords: an integrated resource for microRNA-target interactions

(2008) F. Xiao et al.   NUCLEIC ACIDS RESEARCH

Serum MicroRNAs Are Promising Novel Biomarkers

(2008) Shlomit Gilad et al.   PLoS One

Site-Specific Delivery of Oligonucleotides to Hepatocytes after Systemic Administration

(2007) Lin Zhu et al.   BIOCONJUGATE CHEMISTRY